Woodline Partners’s Taysha Gene Therapies TSHA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.31M | Buy |
1,000,254
+142,000
| +17% | +$328K | 0.01% | 702 |
|
|
2025
Q1 | $1.19M | Sell |
858,254
-169,268
| -16% | -$235K | 0.01% | 745 |
|
|
2024
Q4 | $1.78M | Buy |
1,027,522
+28
| +0% | +$48 | 0.01% | 669 |
|
|
2024
Q3 | $2.07M | Buy |
1,027,494
+1,225
| +0.1% | +$2.46K | 0.02% | 473 |
|
|
2024
Q2 | $2.3M | Buy |
+1,026,269
| New | +$2.3M | 0.02% | 406 |
|